Pancreatic cancer study seeks genetic clues for better risk assessment
NCT ID NCT03060720
First seen Apr 10, 2026 · Last updated May 01, 2026 · Updated 3 times
Summary
This study looks at 271 people with pancreatic cancer to find genetic factors that may increase risk. Researchers will collect personal and family medical history and test for inherited gene changes. The goal is to build a tool that helps doctors identify high-risk patients earlier. Participants also receive genetic counseling and are asked about sharing results with family.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Dana Farber Cancer Institute
Boston, Massachusetts, 02215, United States
Conditions
Explore the condition pages connected to this study.